Learn More
A new cardiotonic agent, (R)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)-phenyl] hydrazono]propanedinitrile (Levosimendan), has been developed and screened for its ability to bind to(More)
BACKGROUND Low serum vitamin D concentrations have been reported in several autoimmune disorders. OBJECTIVE To assess whether low serum vitamin D concentrations are related to disease activity of(More)